« Back
Carisma Shares Unique Engineered Macrophage Cell Therapy Approach at the Inaugural Macrophage-Directed Therapies Summit
Carisma Shares Unique Engineered Macrophage Cell Therapy Approach at the Inaugural Macrophage-Directed Therapies Summit
Oct 21, 2019
Carisma’s VP of Business Development, Dora Mitchell, PhD and VP of Discovery Research, Michael Klichinsky, PharmD, PhD chaired and presented at the inaugural macrophage-directed therapies summit taking place October 22-24, 2019 in Boston, MA. The summit is the only platform dedicated to exploring the translation of macrophage therapies into the clinic. For full agenda and speaker faculty, see here.